Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose in coronary artery disease patients with newly diagnosed type 2 diabetes
2005-004012-78Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Nov 2005
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of acarbose in type 2 diabetes mellitus (T2DM) and coronary arteriosclerosis, sponsored by Medical University of Graz. Primary endpoint: Endothelial function. Started Nov 2005; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-004012-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004012-78.